KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Change in Accured Expenses (2016 - 2025)

Quest Diagnostics' Change in Accured Expenses history spans 17 years, with the latest figure at $16.0 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 54.29% year-over-year to $16.0 million; the TTM value through Dec 2025 reached $129.0 million, up 292.54%, while the annual FY2025 figure was $129.0 million, 292.54% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $16.0 million at Quest Diagnostics, down from $124.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $235.0 million in Q3 2021 and bottomed at -$211.0 million in Q1 2023.
  • The 5-year median for Change in Accured Expenses is $12.5 million (2024), against an average of -$5.4 million.
  • The largest annual shift saw Change in Accured Expenses skyrocketed 2100.0% in 2022 before it plummeted 334.38% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at -$1.0 million in 2021, then surged by 2100.0% to $20.0 million in 2022, then soared by 780.0% to $176.0 million in 2023, then tumbled by 80.11% to $35.0 million in 2024, then plummeted by 54.29% to $16.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Change in Accured Expenses are $16.0 million (Q4 2025), $124.0 million (Q3 2025), and $42.0 million (Q2 2025).